{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-086214","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2024-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.849587+00:00","generated_at":"2026-05-30T17:43:14.757668+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oramed restructures Scilex debt: exchanges $25M note for convertible notes, warrants, and royalty","bullets":["Oramed exchanged $22.5M of its Scilex note for a $25M 5.5% convertible note due 2026 and 3.75M warrants at $1.09.","Oramed exchanged $2.5M of note for a 4.0% royalty on global net sales of ZTlido and SP-103.","Oramed entered binding term sheet for 50% JV with other investors to license lidocaine products outside US, investing $200K/year.","Transactions closed Oct 8, 2024; proceeds repaid $12.5M of Oramed's note and eCapital credit facility.","Scilex issued $50M aggregate convertible notes to Oramed and other investors; Oramed bought $22.5M of that."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-086214","json":"https://secwatch.observer/filing/0001213900-24-086214.json","markdown":"https://secwatch.observer/filing/0001213900-24-086214.md","text":"https://secwatch.observer/filing/0001213900-24-086214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024086214/0001213900-24-086214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024086214/ea0216936-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:43:14.757668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}